Regis Healthcare Limited (ASX:REG) Directors Insider Transactions



The Directors and Chief Executives of Regis Healthcare Limited (ASX:REG) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Regis Healthcare Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Regis Healthcare Limited to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Regis Healthcare Limited Directors/Insider Transactions Activity

List of Insider trades activity from Regis Healthcare Limited (REG).

Date Director Director's Title Shares Value Note
25 Feb 2026 Monaghan (Carmel Anne) Director (Non-Executive) 2,200 10,801 Other at price 4.91 per share.
13 Oct 2025 Mellors (Linda Jane) Chief Executive Officer 419,690 - -
02 Sep 2025 Freeman (Sally Margaret) Independent Non-Executive Director 47,657 242,078 Purchase at price 5.08 per share.
29 Aug 2025 Hodges (Graham Kennedy) Independent Non-Executive Chairman 22,000 111,546 Purchase at price 5.07 per share.
27 Aug 2025 Leonard (Jodie Lee) Independent Non-Executive Director 12,500 64,226 Purchase at price 5.14 per share.
30 Jun 2025 Freeman (Sally Margaret) Independent Non-Executive Director 52,462 - -
30 Jun 2025 Rostolis (Rick C.) Chief Financial Officer 51,240 - -
13 Nov 2024 Leonard (Jodie Lee) Independent Non-Executive Director 7,690 32,564 Purchase at price 4.23 per share.
20 Sep 2024 Mellors (Linda Jane) Chief Executive Officer 71,035 - -
30 Jun 2024 Rostolis (Rick C.) Chief Financial Officer 30,573 - -
30 May 2024 Dorman (Bryan A.) Director (Non-Executive) 17,500,000 45,262,000 Sale at price 2.59 per share.
28 May 2024 Freeman (Sally Margaret) Independent Non-Executive Director 52,462 137,969 Purchase at price 2.63 per share.